NICE rejects Takeda cancer drug over price concerns
July 12, 2010Sales and Marketing Cancer, Mepact, NICE, Takeda, bone cancer
UK cost-effectiveness watchdog NICE has rejected Takeda’s orphan bone cancer drug Mepact due to concerns over price. In its draft …
First oral MS treatment approved in Russia
July 12, 2010Sales and Marketing Cladribine, MS, Merck Serono, Movectro
Regulators in Russia have approved Merck Serono’s cladribine, lining up the drug to be the first oral treatment for multiple …
Annemarie den Broeder joins WorldEvents
July 12, 2010Sales and Marketing WorldEvents, appointment, sales and marketing
UK event agency WorldEvents has appointed Annemarie den Broeder as a senior account manager to its Amsterdam office. Annemarie is …
Steve Meredith joins Ratiopharm
July 12, 2010Sales and Marketing Ratiopharm, appointment, sales and marketing
Ratiopharm Direct has appointed Steve Meredith as northern regional business manager. He will be tasked with playing a key role …
Avoiding insanity in forecasting
July 12, 2010Sales and Marketing forecasts, marketing
The definition of insanity as ‘doing the same thing over and over again and expecting different results’ – is now …
Merck names manufacturing and R&D sites slated for closure
July 12, 2010Manufacturing and Production, Research and Development Merck, job cuts, manufacturing, research and development
Merck & Co has taken an axe to its network of manufacturing and R&D sites around the world, closing down …
Digital Pharma: NICE launches mobile evidence service
July 9, 2010Medical Communications Digital Pharma blog, NHS Evidence, NICE, evidence-based medicine
NICE has launched a mobile version of its online clinical evidence portal NHS Evidence. The beta version of the service …
Pfizer plant ready to milk Asian infant formula market
July 9, 2010Manufacturing and Production Pfizer, Singapore, manufacturing, nutrition
Pfizer has spent $100 million to double the size of a manufacturing facility in Singapore to help it boost its …
Astellas Pharma censured over advisory boards
July 9, 2010Medical Communications, Sales and Marketing Astellas, Code of Practice, PMCPA
Astellas has been the subject of ‘naming and shaming’ advertisements in three medical journals after advisory board meetings it ran …
European call for greater HTA co-operation
July 9, 2010Sales and Marketing hta
The European Commissioner who oversees the pharma sector has called for greater co-operation on health technology assessment. John Dalli, the …
Daisy Thomas joins Hill & Knowlton
July 9, 2010Medical Communications Hill & Knowlton, appointment, medical communications
Hill & Knowlton has appointed Daisy Thomas as an account director to its Healthcare & Wellbeing team. She joins from …
Germany raises health premiums to tackle budget deficit
July 9, 2010Sales and Marketing Germany, economic climate, insurance
Chancellor Angela Merkel’s coalition government has agreed to raise health insurance premiums by over half a percent in a further …
Novel anticoagulants set to lead atrial fibrillation market
July 9, 2010Sales and Marketing Brinavess, Multaq, Pradaxa, Xarelto, apixaban, atrial fibrilation
Novel anticoagulants set to capture the atrial fibrillation market by 2019, according to a new report. Analysts Decision Resources say …
Milestone for UK Biobank
July 8, 2010Research and Development DNA, MRC, UK Biobank, Wellcome
Medical research initiative the UK Biobank has collected DNA samples from its 500,000th volunteer, marking a major milestone in its …
Government has mandate for NHS reform, says Dorrell
July 8, 2010NHS, government
In return for ringfencing the NHS’s budget, the government now has a strong mandate for reforming health services, says the …
Pharming forges production deal with Sanofi Chimie
July 8, 2010Manufacturing and Production, Sales and Marketing HAE, Pharming, Ruconest, Sanofi Chimie
Dutch biotechnology group Pharming has signed a toll manufacturing agreement with Sanofi Chimie in order to boost commercial-scale manufacturing of …
Dr Eliseo Salinas joins Elan
July 8, 2010Research and Development Elan, appointment, research and development
Elan has appointed Dr Eliseo Oreste Salinas as executive VP and chief medical officer with responsibility for leading the company’s …
NICE poised to reject Novartis’ Afinitor
July 8, 2010Sales and Marketing Afinitor, NICE, Novartis
Novartis’ kidney cancer drug Afinitor does not offer enough benefit to patients to justify its cost, according to draft guidance …
Digital Pharma: Big pharma’s iPhone apps (part three)
July 7, 2010Medical Communications, Research and Development, Sales and Marketing Apple, Digital Pharma blog, app, ipad, iphone
In the first two parts of Big Pharma’s iPhone Apps I looked at apps produced by 11 of the largest …
Roche submits new version of Herceptin for US approval
July 7, 2010Research and Development, Sales and Marketing Herceptin, Roche, breast cancer
Roche has submitted a new version of its blockbuster Herceptin (trastuzumab) to US regulators for approval to treat advanced breast …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
